# Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic

> **NCT04927221** · PHASE1 · COMPLETED · sponsor: **Guangzhou JOYO Pharma Co., Ltd** · enrollment: 51 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** DC371739 Tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04927221
- **Lead sponsor:** Guangzhou JOYO Pharma Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2021-12-21
- **Final completion:** 2021-12-21
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2022-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04927221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04927221, "Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04927221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*